Pfizer Rethinks Clinical Research Organisations – CROs

As the Monsters of Pharma Move, things amonst the wild life start to get concerned. There are those that have a symbiotic relationship, with those behemoths, that they need to survive.

n. pl. sym·bi·o·ses (-s?z)
1. Biology A close, prolonged association between two or more different organisms of different species that may, but does not necessarily, benefit each member.
2. A relationship of mutual benefit or dependence.

Amongst the chatter, Clinical Research Organizations (CROs) will be impacted.

Speculation is growing about what contract research organization (CRO) Pfizer (PFE) will choose as a third alliance partner. Rumors spun this week that Quintiles was the front runner, but other sources suggested a privately-owned CRO was to be chosen.

At the April 2014 Partnerships in Clinical Trials (PCT) conference held in Las Vegas, a Pfizer spokeswoman indicated the company was satisfied with their CRO contracts with Icon and Parexel (PRXL), but suggested a third might be chosen. “We are exploring the option of bringing in a third alliance partner but we haven’t made any announcements on this yet.”

At that time, Ross Muken, an analyst with ISI Group suggested Quintiles. “Parexel and Icon shouldn’t be that impacted from a volume standpoint.”

A Quintiles spokesperson said in a statement, that it “does not comment on specific business development efforts,” adding, “Pfizer has been and remains a customer.”

Two privately-owned CROs, PPD and inVentiv (VTIV), considered by some to be the lead prospects if, indeed, Pfizer opts for a third alliance partner, have been ambiguous in their responses to the media.

“As a general policy,” said PPD director of corporate communications and public affairs, Ned Glascock, in a statement, “and because of confidentiality agreements with our clients, I hope you will understand that PPD neither confirms nor denies involvement in any specific study or work with any specific client.”

“We have a long-standing relationship with Pfizer,” said inVentiv spokeswoman Danielle DeForge in a statement, “and continue to provide them with a wide range of best-in-class CRO services to help them achieve their clinical goals faster and with higher quality results.”

Pfizer is withholding specifics, merely stating that it is looking a third clinical trial contractor to supplement existing vendors.

I think Pfizer has gotten tired of those CRO’s pricing, costs, and results. TV ads to enroll, C’mon!

Facebooktwitterredditpinterestlinkedinmailby feather

John Macey

I was born, and principally educated, in the fields of biochemistry, and business management in the northeastern USA. However, my world-wide professional career has greatly expanded upon that US base to involve the many different segments of the Biotech / Life Science fields globally. – I have been dressed as a surgeon to view many, many surgical proceedures - The major players in the health care fields that I have worked for include: Johnson & Johnson, DuPont, Abbott Laboratories, and F. Hoffmann-La Roche. – Positions have included selling nuclear materials for both in-vivo & in-vitro (radio-pharmaceutical & radio-immunoassay) medical diagnostic purposes, in the four countries in Scandinavia, based south of Stockholm, to managing Ph. Ds at a global Swiss headquarters location. – At one time I held a position of Strategy Manager for Europe, Middle-East & Africa (EME&A) for a Chicago based company, but living in Germany. – I do speak fluent colloquial German. – In addition to having lived in multiple European countries, my professional career took me to Asia for well over a decade. There I had management control of Oceania, the Pacific Rim, Northern Asia, Japan, out to India. – Occasionally, management assignments have taken me to all of Latin America, and most of South America. – I am extremely culturally aware, a skilled negotiator, and a seasoned manager of men and science. – My one abiding passion has always been computing, data, and analysis. As such, my main computer operating system is Linux, and open-source computer applications. – I do also run Microsoft 7, and Mac OS X (all 3 operating systems on the same H-P Ultrabook). I hope you enjoy your time on the Blog, and should you have any comments / feedback please feel free to email me @, or visit my Linux Web Site @ (always evolving) – John J. Macey – AKA Adler, which in German means Eagle – Wildwood, New Jersey - Together, we can expand your global markets - with our partnerships. The partnerships are global utlizing multiple Law, Regulatory, Seasoned Management, Employment, M&A and buidlers of Business. Contact use.